COVID 19 second wave – What has changed since the first wave

Madiha Nazer, L. Ragunathan, P. Bharathi, I. Deepika
{"title":"COVID 19 second wave – What has changed since the first wave","authors":"Madiha Nazer, L. Ragunathan, P. Bharathi, I. Deepika","doi":"10.4103/cjhr.cjhr_21_22","DOIUrl":null,"url":null,"abstract":"A pandemic named SARS-COV2 COVID 19 affected many people's life in different ways globally. The normal life is still far away, lockdown rules have been relaxed in many countries. Morbidity and mortality increased a lot after the first wave. COVID-19 has affected medical education in a significant way. Most of the patients were asymptomatic during the second wave and some had symptoms such as myalgia, fever, and cough, which complicated to pneumonia, respiratory distress, and thromboembolic complications. There have been the development of many vaccines such as Covaxin, Pfizer–BioNTech, Covishield, Sputnik V, and Moderna, and these vaccinations have been given to frontline medical workers, people with comorbidities, aged people, etc., with high priority and then the general population. Many pregnant and peripartum women were put on Extracorporeal Membrane Oxygenation (ECMO) in severe to critical cases. A new black fungus was found in post-COVID 19 infections. It was named mucormycosis which usually affected immunocompromised people. There is a high importance in the examination of all the different epidemiological variables of all the places in all the regions across the world, to understand the mutations, and severity of the disease and also to be prepared. Many studies done on COVID-19 in first and the second wave was reviewed in detail and were compared for this review.","PeriodicalId":10321,"journal":{"name":"CHRISMED Journal of Health and Research","volume":"9 1","pages":"219 - 222"},"PeriodicalIF":0.0000,"publicationDate":"2022-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"CHRISMED Journal of Health and Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4103/cjhr.cjhr_21_22","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

A pandemic named SARS-COV2 COVID 19 affected many people's life in different ways globally. The normal life is still far away, lockdown rules have been relaxed in many countries. Morbidity and mortality increased a lot after the first wave. COVID-19 has affected medical education in a significant way. Most of the patients were asymptomatic during the second wave and some had symptoms such as myalgia, fever, and cough, which complicated to pneumonia, respiratory distress, and thromboembolic complications. There have been the development of many vaccines such as Covaxin, Pfizer–BioNTech, Covishield, Sputnik V, and Moderna, and these vaccinations have been given to frontline medical workers, people with comorbidities, aged people, etc., with high priority and then the general population. Many pregnant and peripartum women were put on Extracorporeal Membrane Oxygenation (ECMO) in severe to critical cases. A new black fungus was found in post-COVID 19 infections. It was named mucormycosis which usually affected immunocompromised people. There is a high importance in the examination of all the different epidemiological variables of all the places in all the regions across the world, to understand the mutations, and severity of the disease and also to be prepared. Many studies done on COVID-19 in first and the second wave was reviewed in detail and were compared for this review.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2019冠状病毒病第二波疫情——自第一波疫情以来发生了什么变化
一种名为严重急性呼吸系统综合征冠状病毒2型冠状病毒19型的流行病以不同的方式影响了全球许多人的生活。正常生活仍遥遥无期,许多国家的封锁规定已经放松。第一波疫情后,发病率和死亡率大幅上升。新冠肺炎对医学教育产生了重大影响。大多数患者在第二波中没有症状,有些患者有肌痛、发烧和咳嗽等症状,并伴有肺炎、呼吸窘迫和血栓栓塞并发症。已经开发了许多疫苗,如Covaxin、辉瑞-BioNTech、Covishield、Sputnik V和莫德纳,这些疫苗已优先接种给一线医务工作者、合并症患者、老年人等,然后是普通人群。在严重到危重的病例中,许多孕妇和围产期妇女都接受了体外膜肺氧合(ECMO)。在2019冠状病毒病后感染中发现了一种新的黑真菌。它被命名为毛霉菌病,通常影响免疫功能低下的人。对世界上所有地区所有地方的所有不同流行病学变量进行检查,了解疾病的突变和严重程度,并做好准备,这一点非常重要。详细回顾了第一波和第二波对新冠肺炎的许多研究,并对其进行了比较。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
审稿时长
24 weeks
期刊最新文献
Standardization of objective structured practical examination in terms of validity and reliability in biochemistry: Our first experience Occupational stress: An impediment to quality nurse–Patient relationship – A rapid review COVID-19 positivity in the COVID suspect and green zones of a large emergency department during the first wave of the pandemic in South India Healthcare-seeking behavior and awareness regarding snakebites and its first-aid management among tribal women in rural Maharashtra Hippocratic oath in dentistry: An insight
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1